Access our full library of guidance, white papers, and other resources developed by and for the medical technology industry.
On March 29, AdvaMed responded to the Senate HELP Committee’s request for information on policy priorities for the reauthorization of the Pandemic All-Hazards Preparedness Act (PAHPA).
It is critical for diagnostic test developers to demonstrate the value of their tests to a variety of stakeholders. This framework serves as a resource for members to assess and…
The VALID Act is carefully tailored to ensure continued access to tests offered by academic medical centers and other laboratories.
This report outlines a key data-driven summary of the U.S. COVID testing supply.
AdvaMed submitted a letter to Medicare Administrative Contractors, Novitas and First Coast Service Options, regarding proposed LCDs on Genetic Testing in Oncology.
Brought to you by AdvaMed, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
This report examines cumulative data from the first two years of the COVID Test Registry to demonstrate the mobilization of the diagnostics industry over the course of the pandemic.
Read a section-by-section breakdown of the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021.
AdvaMed and AdvaMedDx have prioritized supporting Medtech’s mobilization to the pandemic to protect patients and public health.